-
First participants dosed in new POINT-HD huntingtin-lowering trial
Latest News
-
A road less traveled: how making less huntingtin can alter somatic instability and may delay symptoms
CAG repeats can get longer over time as the HD gene is used, like the growing potholes and cracks in an old road. New research finds that blocking cells from using their HTT gene slows this wear and tear, which might slow the onset of symptoms in HD.
-
Positive results announced for re-worked tetrabenazine drug in Huntington's disease
Modified 'heavy hydrogen' form of tetrabenazine appears safe and effective for chorea in Huntington's disease
-
Turning skin cells into brain cells: a Huntington's disease research breakthrough?
Scientists can now change human skin cells into working neurons, like the ones that are most affected in HD.
-
Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015
A clinical trial for an exciting therapy against HD is planned for 2015. The first step is to make sure it is safe.
-
Largest creatine clinical trial for Huntington's disease halted after 'futility' analysis
CREST-E, a trial of the supplement creatine, has been stopped after an early analysis found it couldn't show benefit
-
Should we worry about a huntingtin invasion?
Cool lab experiments show the huntington's disease protein jumping between cells. Does this matter for HD patients?
-
EuroBuzz 2014 Video, day one
Video of our first live session at the European Huntington's Disease Network Meeting.
-
EuroBuzz 2014 Video, day two
Video of our second live session at the European Huntington's Disease Network Meeting.
-
Melatonin alterations in Huntington's disease help explain trouble with sleep
Study shows HD patients have decreased levels of melatonin, which may explain why so many suffer from sleep problems
-
EuroBuzz 2014: day three
Our third and final report on the 2014 European Huntington's Disease Network meeting in Barcelona
-
EuroBuzz 2014: day two
HDBuzz reports on the second day of science at the European HD Network meeting in Barcelona
